All tenders
75N95023F00005
Buprenorphine Induction Study: Standard and High Dose
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N95023F00005
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- Buprenorphine Induction Study: Standard and High Dose
- Source
- USASpending (Federal)
- Source ID
- usa-75N95023F00005
Details
- Location
- United States
Summary
A research study examining standard and high-dose buprenorphine induction methods in emergency departments, spanning from September 2023 to May 2026. The study aims to investigate different approaches to medication-assisted treatment for substance use disorders.
Description
STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9). Awarded to: THE EMMES COMPANY, LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER
Dates
- Publication
- 2023/09/15 12:00:00 AM UTC
- Closing date
- 2027/01/31 12:00:00 AM UTC
Estimated value
$1.2M USD
Classification
Normalized category
Other